BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 36935318)

  • 1. Parenteral nutrition at the palliative phase of advanced cancer: the ALIM-K study protocol for a randomized controlled trial.
    Pazart L; Cretin E; Grodard G; Cornet C; Mathieu-Nicot F; Bonnetain F; Mercier M; Cuynet P; Bouleuc C; Aubry R;
    Trials; 2014 Sep; 15():370. PubMed ID: 25248371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral Nutrition in Palliative Cancer Care: Detrimental, Futile, or Beneficial?
    Løhre ET; Solheim TS; Jakobsen G; Vagnildhaug OM; Schmidberger Karlsen TL; Habberstad RH; Balstad TR; Thronæs M
    Curr Oncol; 2024 May; 31(5):2748-2757. PubMed ID: 38785489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional care pathways in cancer patients with malignant bowel obstruction: A retrospective multi-centre study.
    Patel PS; Fragkos K; Keane N; Wilkinson D; Johnson A; Chan D; Roberts B; Neild P; Yalcin M; Allan P; FitzPatrick MEB; Gomez M; Williams S; Kok K; Sharkey L; Swift C; Mehta S; Naghibi M; Mountford C; Forbes A; Rahman F; Di Caro S
    Clin Nutr ESPEN; 2024 Feb; 59():118-125. PubMed ID: 38220364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice of parenteral nutrition in hospitalized adult patients in Korea: A retrospective multicenter cross-sectional study.
    Park HJ; Kim JT; Chung JE; Yang JA; Bae HJ; Sung YW; Park JE; Kim SH; Cho JY; Jung KM; Bae HK
    PLoS One; 2020; 15(4):e0230922. PubMed ID: 32236124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction.
    Velasquez DA; Dhiman A; Brottman C; Eng OS; Fenton E; Herlitz J; Lozano E; McDonald E; Reynolds V; Wall E; Whitridge J; Semrad C; Turaga K; Micic D
    Support Care Cancer; 2024 Mar; 32(3):206. PubMed ID: 38433169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral nutrition.
    Ghosh D; Neild P
    Clin Med (Lond); 2010 Dec; 10(6):620-3. PubMed ID: 21413491
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the management of intracystic papillary carcinoma.
    Beck M; Beltjens F; Arnould L; Coutant C; Vincent L
    Bull Cancer; 2023; 110(7-8):810-817. PubMed ID: 37179238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The announcement of treatment resistance in pediatric oncology: Understanding parents' experiences and influencing factors with a mixed methodology].
    Terrasson J; Rault A; Seigneur É; Brédart A; Dolbeault S
    Bull Cancer; 2023; 110(7-8):746-757. PubMed ID: 37100684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination strategies for checkpoint inhibition: Current practices and perspectives].
    Dussart C; Decaux-Tramoni B; Quesada S; Thomas QD; Benzerouale O; Nicolas E; Fiteni F
    Bull Cancer; 2023; 110(7-8):790-801. PubMed ID: 37055309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatments for rare ovarian tumors: What's new?].
    Lebreton C; Quesada S; Bini M; Babin G; Rossi L; Chopin N; Croce S; Hartog C; Renaud T; Gaillard AL; Petit A; Serre AA; Trédan O; Rowinski E; Cockenpot V; Treilleux I; Rousset-Jablonski C; Méeus P; Guyon F; Ray-Coquard I
    Bull Cancer; 2023; 110(7-8):818-824. PubMed ID: 37045734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The "Gradation instruction" of care: An opportunity to integrate clinical pharmacy activities in the cancer patient journey].
    Cormier N; Bedoucha C; Roux-Marson C; Valery A; Dufossez F
    Bull Cancer; 2023; 110(7-8):802-809. PubMed ID: 36959042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the human microbiome in frequent cancers, current knowledge and carcinogenesis mechanisms.
    Ait-Zenati F; Djoudi F; Mehelleb D; Madaoui M
    Bull Cancer; 2023; 110(7-8):776-789. PubMed ID: 36959041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of parenteral nutrition prescription in Canadian acute care settings.
    Adjemian D; Arendt BM; Allard JP
    Nutrition; 2018 May; 49():7-12. PubMed ID: 29571609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse effects of parenteral nutrition in cancer patients: systematic review].
    Wanden-Berghe C; Sanz-Valero J; García de Lorenzo A; Martín-Peña G; Cervera M; Luengo L; Martín-Folgueras T; Laborda L;
    Nutr Hosp; 2012; 27(2):409-18. PubMed ID: 22732962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications and complications of inpatient parenteral nutrition prescribed to children in a large tertiary referral hospital.
    Mantegazza C; Landy N; Zuccotti GV; Köglmeier J
    Ital J Pediatr; 2018 Jun; 44(1):66. PubMed ID: 29880053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolving Malnutrition With Parenteral Nutrition Before Liver Transplant in Biliary Atresia.
    Wendel D; Mortensen M; Harmeson A; Shaffer ML; Hsu E; Horslen S
    J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):212-217. PubMed ID: 29356765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use and Misuse of Parenteral Nutrition in Patients with Inflammatory Bowel Disease.
    Nelson AD; Elkins JR; Stocchi L; Farraye FA; Hashash JG
    Inflamm Bowel Dis; 2022 Oct; 28(10):1592-1602. PubMed ID: 35472221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of parenteral nutrition practices in a comprehensive cancer center: Comparative audits.
    Peinoit A; Muzellec L; Som M; Edeline J; Thibault R; Neveu E; Vauleon E
    Bull Cancer; 2023; 110(7-8):758-767. PubMed ID: 36935318
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.